TIAA CREF Investment Management’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $1.21M | Buy |
79,728
+676
| +0.9% | +$10.2K | ﹤0.01% | 2229 |
|
|
2018
Q4 | $1.36M | Buy |
79,052
+2,014
| +3% | +$34.6K | ﹤0.01% | 2161 |
|
|
2018
Q3 | $1.14M | Sell |
77,038
-7,211
| -9% | -$106K | ﹤0.01% | 2370 |
|
|
2018
Q2 | $2.01M | Buy |
84,249
+24,429
| +41% | +$583K | ﹤0.01% | 2169 |
|
|
2018
Q1 | $1.53M | Buy |
59,820
+377
| +0.6% | +$9.63K | ﹤0.01% | 2245 |
|
|
2017
Q4 | $1.1M | Buy |
59,443
+281
| +0.5% | +$5.19K | ﹤0.01% | 2419 |
|
|
2017
Q3 | $621K | Sell |
59,162
-2,025
| -3% | -$21.3K | ﹤0.01% | 2733 |
|
|
2017
Q2 | $765K | Buy |
61,187
+18,691
| +44% | +$234K | ﹤0.01% | 2671 |
|
|
2017
Q1 | $428K | Sell |
42,496
-1,499
| -3% | -$15.1K | ﹤0.01% | 2837 |
|
|
2016
Q4 | $685K | Buy |
43,995
+1,234
| +3% | +$19.2K | ﹤0.01% | 2711 |
|
|
2016
Q3 | $824 | Hold |
42,761
| – | – | ﹤0.01% | 2634 |
|
|
2016
Q2 | $507K | Buy |
42,761
+19,275
| +82% | +$229K | ﹤0.01% | 2848 |
|
|
2016
Q1 | $426K | Sell |
23,486
-4,774
| -17% | -$86.6K | ﹤0.01% | 2830 |
|
|
2015
Q4 | $777K | Buy |
28,260
+2,498
| +10% | +$68.7K | ﹤0.01% | 2728 |
|
|
2015
Q3 | $570K | Buy |
25,762
+18,569
| +258% | +$411K | ﹤0.01% | 2845 |
|
|
2015
Q2 | $128K | Buy |
+7,193
| New | +$128K | ﹤0.01% | 3144 |
|